Research | Roundhill Investments

Not all covered call strategies are created equally. Roundhill’s suite of innovative...

Not all covered call strategies are created equally. Roundhill’s suite of innovative...

The GLP-1 and weight loss drug landscape is teeming with innovation as companies test drugs with...

As we approach the end of the year, the outlook for stocks remains generally positive, buoyed by a...

Since the introduction of the “ETF Rule” in 2019, actively-managed ETFs using options, swaps, and...

Why do the Funds use a “synthetic” long position? Roundhill’s suite of zero-days-to-expiry (“0DTE”)...

While the U.S. boasts the Magnificent Seven stocks – some of the dominant tech companies shaping...

In the lead-up to the second quarter 2024 earnings season, the Magnificent Seven stocks were at a...

Inflationary Wave & Election Volatility Imminent? Following a 50 bps rate cut at September's widely...

People’s Bank of China Fires the Bazooka In pursuit of its 5% growth target, the People’s Bank of...

The Easing Cycle Begins In the most anticipated Federal Open Market Committee meeting since the...

Small Caps Haven’t Made a High Since… Small caps have been difficult for investors in recent years,...

Investors who want to earn a reliable income from their investments while seeking to minimize some...

In early August, equity volatility spiked to levels last seen in 2020, reflecting market jitters...

Roughly 95% of the S&P 500 have reported earnings results for 2Q’24. With a beat rate of roughly...

Latest Research & Insights